EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analysis of GEN1 as a Breast Cancer Susceptibility Gene in Polish Women

Katarzyna Gliniewicz iD, Dominika Wokołorczyk, Wojciech Kluźniak iD, Klaudia Stempa iD, Tomasz Huzarski, Helena Rudnicka, Anna Jakubowska iD, Marek Szwiec iD, Joanna Jarkiewicz-Tretyn, Magdalena Cechowska, Paweł Domagała iD, Tadeusz Dębniak iD und 6 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26135991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Katarzyna Gliniewicz und 17 weiteren Autor:innen. Beteiligte Einrichtung: International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland. Hauptthemen laut MEDLINE: Breast Neoplasms, Genetic Predisposition to Disease. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GEN1 is implicated in DNA damage repair, as are several other breast cancer susceptibility genes, and is included in several comprehensive next-generation sequencing (NGS) testing panels. To investigate the possible association of GEN1 variants with breast cancer risk, we sequenced this gene in 617 Polish women with hereditary breast cancer (HBC) and 300 Polish cancer-free controls. No protein-truncating variants were detected in the conserved part of GEN1 (first 480 codons). Two frameshift variants were detected in the last exon of GEN1: c.2515_2519delAAGTT (p.Lys839Glufs*2) and c.1929_1932delAAAG (p.Lys645Cysfs*29). The p.Lys839Glufs*2 variant was detected in 21.1% of 617 HBC cases and 18.4% of 300 controls (p = 0.38). The p.Lys645Cysfs*29 variant was rare, seen in 0.6% of 617 HBC cases and 0.3% of 300 controls. The variant was then detected in 38 (0.24%) of 15,930 unselected breast cancer cases and 8 (0.17%) of 4702 cancer-free female controls from Poland (OR = 1.40, p = 0.49). Clinical characteristics of breast tumors in the 38 carriers of p.Lys645Cysfs*29 and 15,892 non-carriers were similar. Survival was similar among variant carriers and non-carriers (the age-adjusted HR = 0.87, p = 0.76). The wild-type GEN1 allele was retained in all five breast cancers of carriers of p.Lys645Cysfs*29. No cancer type was more frequent in the relatives of 35 p.Lys645Cysfs*29 variant carriers compared to the relatives of 14,592 non-carriers. We conclude that GEN1 is unlikely to be a high or moderate-risk breast cancer susceptibility gene. Our study has clinical implications for genetic counseling and suggests that GEN1 changes should be reclassified as variants of uncertain significance (VUS) when they are detected in clinical testing panels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGenetic Predisposition to DiseaseHumansFemalePolandMiddle AgedAdultCase-Control StudiesAged

Stichwörter der Autor:innen

GEN1cancergermline mutationssusceptibility

Autor:innen und Institutionen

  • International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
  • Department of Clinical Genetics and Pathology, University of Zielona Góra, 65-046 Zielona Góra, Poland.
  • Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
  • Department of Surgery and Oncology, University of Zielona Góra, 65-046 Zielona Góra, Poland.
  • Cancer Genetics Laboratory, 87-100 Toruń, Poland.
  • Women's College Research Institute, Women's College Hospital, Toronto, ON M5S 1B2, Canada.

ORCID-Profile: Katarzyna Gliniewicz, Wojciech Kluźniak, Klaudia Stempa, Anna Jakubowska, Marek Szwiec, Paweł Domagała, Tadeusz Dębniak, Jacek Gronwald, Jan Lubiński, Steven A Narod, Cezary Cybulski

Förderung

  • National Science Centre, Poland

Zitieren

APA

Gliniewicz, K., Wokołorczyk, D., Kluźniak, W., Stempa, K., Huzarski, T., Rudnicka, H., Jakubowska, A., Szwiec, M., Jarkiewicz-Tretyn, J., Cechowska, M., Domagała, P., Dębniak, T., Lener, M., Gronwald, J., Lubiński, J., Narod, S. A., Akbari, M. R., & Cybulski, C. (2025). Analysis of GEN1 as a Breast Cancer Susceptibility Gene in Polish Women. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26135991

Vancouver

Gliniewicz K, Wokołorczyk D, Kluźniak W, Stempa K, Huzarski T, Rudnicka H, et al. Analysis of GEN1 as a Breast Cancer Susceptibility Gene in Polish Women. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26135991

BibTeX
@article{Gliniewicz2025,
  author = {Gliniewicz, Katarzyna and Wokołorczyk, Dominika and Kluźniak, Wojciech and Stempa, Klaudia and Huzarski, Tomasz and Rudnicka, Helena and Jakubowska, Anna and Szwiec, Marek and Jarkiewicz-Tretyn, Joanna and Cechowska, Magdalena and Domagała, Paweł and Dębniak, Tadeusz and Lener, Marcin and Gronwald, Jacek and Lubiński, Jan and Narod, Steven A and Akbari, Mohammad R and Cybulski, Cezary},
  title = {Analysis of GEN1 as a Breast Cancer Susceptibility Gene in Polish Women},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26135991}
}
Kostenlos starten →